The company has been granted with an investment co-financed by the Republic of Slovenia and the European Union under the European Regional Development Funds.
MESI entered the Romanian market with its product for measuring Ankle-Brachial Index, MESI ABPI MD, in the year 2013. The sales achieved since then showed us that the Romanian market has excellent potential for expending MESI presence on the market and its product portfolio. Therefore, the next logical step was to launch a next-generation ABI measuring device, MESI mTABLET ABI, together with TBI, ECG, SPO2 and BP extensions.
MESI mTABLET ABI offers PADsense™ algorithm for detection of severe Peripheral Arterial Disease, 3CUFF™ technology allowing simultaneous measurements and quick and reliable ABI measurement with pulse waveform interpretation. The product was created with a modern healthcare practice in mind.
We have joined the Project with the goal to expand our presence on the Romanian market, together with the partner launch the MESI mTABLET ABI, and with various promotional activities generate new leads which will result in sales.
The first impressions from introducing the new device are very optimistic. The customers are inquisitive about the product as well as very open to new technology and all the features MESI mTABLET ABI brings to the healthcare practice.